𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Acute effect of glipizide on glucose tolerance in obesity and diabetes mellitus (NIDDM)

✍ Scribed by A. E. Pontiroli; M. G. Perfetti; G. Pozza

Publisher
Springer
Year
1991
Tongue
English
Weight
381 KB
Volume
40
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

✦ Synopsis

The attempt has been made to identity the lowest dose of glipizide, a second generation sulphonylurea, capable of improving glucose tolerance in overweight and obese subjects with various degrees of glucose tolerance. Thirty one obese subjects, 12 with non insulin dependent diabetes mellitus (NIDDM), 9 with impaired glucose tolerance (IGT) and 10 with normal glucose tolerance (NGT) each underwent four OGTTS (75 g), at 1 week intervals, after administration in random order of placebo or glipizide 0.5, 1.0 or 2.5 mg 30 min before glucose. Glucose tolerance in all groups was progressively improved by the increasing doses of glipizide and was normalized by 1.0 mg glipizide in impaired glucose tolerance (IGT) and by 2.5 mg glipizide in NIDDM. Insulin release was not significantly affected by glipizide in the three groups of subjects. The data indicate that it is possible, at least in acute experiments, to improve glucose tolerance in overweight and obese subjects with IGT, with NGT and with NIDDM, with doses of glipizide that do not affect insulin release.

πŸ“œ SIMILAR VOLUMES

Effects of ingested fructose and infused
Effects of ingested fructose and infused glucagon on endogenous glucose production in obese NIDDM patients, obese non-diabetic subjects, and healthy subjects
✍ N. Paquot; Ph. Schneiter; E. JΓ©quier; R. Gaillard; P. J. LefΓ¨bvre; A. Scheen; L. πŸ“‚ Article πŸ“… 1996 πŸ› Springer 🌐 English βš– 825 KB

Increased endogenous glucose production (EGP) and gluconeogenesis contribute to the pathogenesis of hyperglycaemia in non-insulin-dependent diabetes mellitus (NIDDM). In healthy subjects, however, EGP remains constant during administration of gluconeogenic precursors. This study was performed in ord

Long-term effects of glipizide on insuli
Long-term effects of glipizide on insulin secretion and blood glucose control in patients with non-insulin-dependent diabetes mellitus
✍ P.-O. BitzΓ©n; A. Melander; B. ScherstΓ©n; M. Svensson; E. WΓ₯hlin-Boll πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 638 KB

Of 23 patients with non-insulin-dependent diabetes mellitus (NIDDM), whose fasting blood glucose had not reached less than or equal to 6.0 mmol.l-1 after 10 weeks of dietary regulation, 15, who had had a weight reduction of -2.8 kg by dietary control, did achieve a fasting blood glucose less than or

Prevalence of diabetes mellitus and impa
Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes
✍ J. A. S. McLellan; B. A. Barrow; J. C. Levy; M. S. Hammersley; A. T. Hattersley; πŸ“‚ Article πŸ“… 1995 πŸ› Springer 🌐 English βš– 555 KB

Nuclear families of non-insulin-dependent diabetic (NIDDM) patients are uncommon, as usually one or both parents have died. In order to aid identification of complete nuclear families, we have ascertained the disease process at a younger age by studying subjects with previous gestational diabetes. O

Linogliride fumarate, an oral hypoglycem
Linogliride fumarate, an oral hypoglycemic agent, improves oral glucose tolerance in a rat model of non-insulin-dependent diabetes mellitus (NIDDM)
✍ Carol S. Marchione; Robert W. Tuman πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 472 KB

Marchione, C.S., and R.W. Tuman: Linogliride fumarate, an oral hypoglycemic agent, improves oral glucose tolerance in a rat model of non-insulin-dependent diabetes mellitus (NIDDM). Drug Dev. Res. 17:161-168, 1989. Linogliride fumarate, a structurally novel oral hypoglycemic compound, was tested in